A class-structured reference for formulary rationalisation, tender-lot design and benchmarking. Search by generic, brand, class or ATC; filter by therapeutic area and procurement flags. Every entry lists same-class alternatives, common forms and strengths, brand examples for India and the UAE/GCC, and practitioner procurement notes.
1,113entries
104therapeutic classes
23clinical areas
10procurement flags
28 Oct 2026version
· Brand names are examples and belong to their owners· Click a class or an alternative to pivot
Cold chain: Store 2–8 °C; temperature-logged transport and storage · Controlled: Narcotic / psychotropic / controlled-drug licensing and register · High-alert: ISMP high-alert medication — storage, labelling and double-check controls · Biologic / biosimilar: Biosimilars available or emerging — tender with interchangeability criteria · Reserve / restricted: Stewardship-restricted, specialist or very high cost — patient-level approval · Cytotoxic: Closed-system handling, trained staff, cytotoxic waste · WHO EML: On the WHO Model List of Essential Medicines · India NLEM: On India National List of Essential Medicines (price-controlled) · LASA: Look-alike / sound-alike risk · Narrow TI: Narrow therapeutic index — brand consistency, level monitoring
Procurement reference, not clinical guidance. Alternatives are listed at class or therapeutic level to help design tender lots and formulary reviews; they are not statements of clinical equivalence. Any substitution needs Pharmacy & Therapeutics / clinician approval, and registration status must be checked with the relevant authority (CDSCO, MOHAP, DoH, DHA, SFDA). Compiled and maintained by Consulting Wallah practitioners; viewable free on this page; not for redistribution or scraping (CC BY-NC-ND). To suggest a correction or a missing molecule, use the contact form.
Want this applied to your formulary?Free executive assessment for hospital leaders — spend snapshot, class-level tender lots, biosimilar and IV→oral opportunities.